A detailed history of Redmont Wealth Advisors LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Redmont Wealth Advisors LLC holds 51 shares of LLY stock, worth $40,197. This represents 0.07% of its overall portfolio holdings.

Number of Shares
51
Previous 51 -0.0%
Holding current value
$40,197
Previous $46,000 2.17%
% of portfolio
0.07%
Previous 0.08%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 19, 2024

BUY
$592.2 - $792.28 $30,202 - $40,406
51 New
51 $39,000
Q3 2022

Nov 14, 2022

BUY
$296.48 - $337.87 $296 - $337
1 Added 0.03%
3,001 $970,000
Q4 2021

Feb 14, 2022

BUY
$224.85 - $279.04 $674,550 - $837,120
3,000 New
3,000 $829,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $749B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Redmont Wealth Advisors LLC Portfolio

Follow Redmont Wealth Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Redmont Wealth Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Redmont Wealth Advisors LLC with notifications on news.